HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 5.42
Day range
kr 5.30 - kr 5.53
Year range
kr 1.04 - kr 6.56
Market cap
1.37B SEK
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 20.21M | 137.62% |
Operating expense | 66.98M | -3.01% |
Net income | -60.89M | -1.10% |
Net profit margin | -301.25 | 57.45% |
Earnings per share | — | — |
EBITDA | -46.43M | 23.43% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 147.92M | -40.84% |
Total assets | 211.28M | -33.81% |
Total liabilities | 204.74M | 11.54% |
Total equity | 6.54M | — |
Shares outstanding | 272.71M | — |
Price to book | 271.00 | — |
Return on assets | -67.66% | — |
Return on capital | -104.35% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -60.89M | -1.10% |
Cash from operations | -33.70M | 74.17% |
Cash from investing | — | — |
Cash from financing | 111.58M | 5,804.45% |
Net change in cash | 77.77M | 158.36% |
Free cash flow | -47.80M | 58.44% |
About
CEO
Founded
2000
Website
Employees
75
